Skip to main content

Advertisement

Table 3 Multiple linear regression models with ANP as a dependent variable with adjustment for exenatide concentration

From: Exenatide infusion decreases atrial natriuretic peptide levels by reducing cardiac filling pressures in type 2 diabetes patients with decompensated congestive heart failure

Variable ß (95 % CI) P Adjusted R2
PAP 2.0 (0.3, 3.8) 0.025 0.19
PCWP 4.0 (0.8, 7.3) 0.017 0.22
RAP 5.6 (2.3, 8.9) 0.002 0.38
  1. ß unstandardized regression-coefficient adjusted for exenatide concentration, PAP mean pulmonary arterial pressure, PCWP pulmonary capillary wedge pressure, RAP right atrial pressure